Novel Inhibitors of Leukotrienes
Series: Progress in Inflammation Research;
- Publisher's listprice EUR 213.99
-
92 475 Ft (88 072 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 18 495 Ft off)
- Discounted price 73 980 Ft (70 458 Ft + 5% VAT)
92 475 Ft
Availability
It is in stock and you can get your copy fast. We can prepare it for shipment very soon or you can pick it up in our office. Your order will be held for 5 working days after you receive your "ready for pickup" email.
Our current stock: 1 copy
Product details:
- Edition number 1999
- Publisher Birkhäuser
- Date of Publication 1 September 1999
- Number of Volumes 1 pieces, Book
- ISBN 9783764358846
- Binding Hardback
- No. of pages347 pages
- Size 235x155 mm
- Weight 1510 g
- Language English
- Illustrations XII, 347 p. Illustrations, black & white 0
Categories
Short description:
Many new antileukotriene drugs are now marketed as antiasthma drugs and
represent the first new drugs in this field since the 1970s. This book
covers the steps that have led to the discovery and development of these
new drugs and offers detailed descriptions of their clinical
applications.
The volume takes a new approach in presenting information of particular
interest to both scientists and clinicians...
Long description:
Many new antileukotriene drugs are now marketed as antiasthma drugs and
represent the first new drugs in this field since the 1970s. This book
covers the steps that have led to the discovery and development of these
new drugs and offers detailed descriptions of their clinical
applications. The review chapters on the main aspects of basic and
applied leukotriene research are written by leading specialists in the
field, and the volume takes a new approach in presenting information of
particular interest to both scientists and clinicians in the fields of
asthma, inflammation and allergic diseases.
Table of Contents:
5-Lipoxygenase.- LTC4 synthase: A key enzyme in cysteinyl leukotriene formation.- Leukotriene A4 hydrolase: A key enzyme in chemotactic leukotriene formation.- Metabolism of leukotrienes and formation of new leukotriene structures.- Receptors for cysteinyl-leukotrienes: Targets for new drugs.- Targeted disruption of 5-lipoxygenase.- Transcellular biosynthesis of leukotrienes: A unique mode of cell communication.- Physiological and pathophysiological activities of leukotrienes.- Entry rate and metabolic handling of LTC4 in the human circulation.- Genetic polymorphisms of 5-LO.- Leukotrienes and aspirin-intolerant asthma.- Leukotrienes in nocturnal asthma.- Leukotrienes and allergic asthma.- Inhibitors of leukotrienes: An overview.- The development of zafirlukast (Accolate?) and the Zeneca series of peptidyl-leukotriene receptor antagonists.- The development of zileuton (ZYFLO?) and the N-hydroxyurea class of 5-lipoxygenase inhibitors.- The development of BAY X 1005 and the Bayer series of leukotriene biosynthesis inhibitors.- The development of iralukast: A member of the Novartis series of cysteinyl leukotriene antagonists.- LTB4 receptor antagonists.- SmithKline Beecham pharmaceuticals? cysteinyl leukotriene receptor antagonists: Pranlukast (SB 205312; Ono-1078; Onon), Pobilukast (SK&F 104353) and SK&F 106203.
More
Novel Inhibitors of Leukotrienes
Subcribe now and receive a favourable price.
Subscribe
92 475 HUF
